Investing.com - Financial Markets Worldwide
⚠ Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Tilray Inc (TLRY)

NASDAQ
Symbol
Exchange
Currency
TLRYNASDAQUSD
TLRYTorontoCAD
2HQXetraEUR
2HQFrankfurtEUR
2HQTradeGateEUR
TLRYViennaEUR
Currency in USD
Disclaimer
1.590
-0.040(-2.45%)
Closed
After Hours
1.5900.000(0.00%)

TLRY Comments

I thought we were all gonna get Rich from this today oh bummer I guess go back to your day job
I think Simon should think more like Elon Musk, Simon probably already got 100 million dollars out of Tilray and has his house in the Hamptons. With the current financial performance of Tilray there is no way Simon is justified in making 15 million a year. He should think about Shareholder Value next year, if he did he would probably be the 1st cannabis billionaire by now. But Simon is a narcissist.
couldn't agree with your more. shareholders should demand his resignation.
I think Simon should think more like Elon Musk, Simon probably already got 100 million dollars out of Tilray and has his house in the Hamptons. With the current financial performance of Tilray there is no way Simon is justified in making 15 million a year. He should think about Shareholder Value next year, if he did he would probably be the 1st cannabis billionaire by now. But Simon is a narcissist. Please go simon and enjoy your pocket money. You will never be a billionaire. Please go
so Tilray is good at the sideline but sucks when it cmes to core business. go figure.
seriously, have the quarterly announcements been that bad again? the stock price has plummeted again. i can't believe it... we're screwed..
I was thinking it could go up till en of the year slowly. It is so dangerous, it jumps to 2.5-3 then back 1.7-1.5. It can not resist, I hope it will back to above 2 dollars again then sell and get rid of it. No hope, we all say it will go up 10-20 but this is a stock for short term earn, they can get money then sell for expenses so business is not good. There is no any upside sign since 3-4 years. It always stay in 2-3 then back and I hope this time it will not see 1 and lower then...
I think that if they disqualify the drug as less dangerous it would be very beneficial for the company because they could use it as a medicinal use and these companies would go up I don't see it very strange
added at 1.48 .
LIES !
results have a few upsides as well. let s see how this is bought / sold by the investors. i d say a hike above 1.63 could probably be interpreted as positive.
I think that when they disqualify it as a less dangerous drug it will be good for the sector and especially for these companies because they could use it as a medicinal use it would greatly favor the sector
so the challenges are: tilray spent a lot especially to get the beverages business some traction, lifestyle cannabis sales dropped especially in canada and not much improvement on medical sales.
i see a revenue decrease in canada on the cannabis front but no mention of us. can t tilray get any significant sales in the us? legal hurdles?
the so-called restructring costs have quintupled to 4.5 million. selling costs rose by about 80.percent to 11.69 million and marketing costs have soared to 11.6 million by 35 percent. i believe these are mostly related to the beverages business.
fire mgmt, this is stealing by incompetence!
gross profit seems to have increased by around 45 percent y-o-y. financial and interest expenses seemed to have dropped and non operating income is a whopping 12 million. so it is the operating costs that is the problem.
The salary of simon is a big problem
lol!
real junk !
Simon is happy with his 15 mln salary
It gets what it deserves unfortunately. I am so disappointed.
beverage business has now doubled and makes up for most of the year on year increase in revenue which is good, but in the meantime costs seem to have tripled, that should have drained the profit.
the reduction comes from the decline of sales, in Canada and abroad. interesting. i was under the impression that Tilray was making inroads into the European and other markets.
ebitda is down 9 percent down y-o-y despite increased revenues. aside from that net revenues from cannabis seem to have dropped by about 12 percent. tilray does not make as much dough from its core business as it did last year. not a very pretty sight imho.
I think 4-5 dollars is a dream
so what's next for tilray...revenue still fall short despite acquisition...
revenue is below expectations , but up from 177 m to 200 m ,,,, so what ?? whose expectation is it ?? i personally thonk tilray is a strong buy at this market valuation ,,,,,
TODAY :) EPS / Forecast -- / -0.04 Revenue / Forecast -- / 218.88M
TRUMP 2024
Trump supports cannabis treatments.
Gap closed...Bought 1.62...currently oversold...tight stop loss....earnings AM
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.